13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Astrocyte reactivity after brain injury—: The role of galectins 1 and 3

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Astrocytes react to brain injury in a heterogeneous manner with only a subset resuming proliferation and acquiring stem cell properties in vitro. In order to identify novel regulators of this subset, we performed genomewide expression analysis of reactive astrocytes isolated 5 days after stab wound injury from the gray matter of adult mouse cerebral cortex. The expression pattern was compared with astrocytes from intact cortex and adult neural stem cells (NSCs) isolated from the subependymal zone (SEZ). These comparisons revealed a set of genes expressed at higher levels in both endogenous NSCs and reactive astrocytes, including two lectins—Galectins 1 and 3. These results and the pattern of Galectin expression in the lesioned brain led us to examine the functional significance of these lectins in brains of mice lacking Galectins 1 and 3. Following stab wound injury, astrocyte reactivity including glial fibrillary acidic protein expression, proliferation and neurosphere‐forming capacity were found significantly reduced in mutant animals. This phenotype could be recapitulated in vitro and was fully rescued by addition of Galectin 3, but not of Galectin 1. Thus, Galectins 1 and 3 play key roles in regulating the proliferative and NSC potential of a subset of reactive astrocytes. GLIA 2015;63:2340–2361

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Galectins as modulators of tumour progression.

          Galectins are a family of animal lectins with diverse biological activities. They function both extracellularly, by interacting with cell-surface and extracellular matrix glycoproteins and glycolipids, and intracellularly, by interacting with cytoplasmic and nuclear proteins to modulate signalling pathways. Current research indicates that galectins have important roles in cancer; they contribute to neoplastic transformation, tumour cell survival, angiogenesis and tumour metastasis. They can modulate the immune and inflammatory responses and might have a key role helping tumours to escape immune surveillance. How do the different members of the Galectin family contribute to these diverse aspects of tumour biology?
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prospective identification and purification of quiescent adult neural stem cells from their in vivo niche.

            Adult neurogenic niches harbor quiescent neural stem cells; however, their in vivo identity has been elusive. Here, we prospectively isolate GFAP(+)CD133(+) (quiescent neural stem cells [qNSCs]) and GFAP(+)CD133(+)EGFR(+) (activated neural stem cells [aNSCs]) from the adult ventricular-subventricular zone. aNSCs are rapidly cycling, highly neurogenic in vivo, and enriched in colony-forming cells in vitro. In contrast, qNSCs are largely dormant in vivo, generate olfactory bulb interneurons with slower kinetics, and only rarely form colonies in vitro. Moreover, qNSCs are Nestin negative, a marker widely used for neural stem cells. Upon activation, qNSCs upregulate Nestin and EGFR and become highly proliferative. Notably, qNSCs and aNSCs can interconvert in vitro. Transcriptome analysis reveals that qNSCs share features with quiescent stem cells from other organs. Finally, small-molecule screening identified the GPCR ligands, S1P and PGD2, as factors that actively maintain the quiescent state of qNSCs. Copyright © 2014 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain.

              Reactive gliosis is the universal reaction to brain injury, but the precise origin and subsequent fate of the glial cells reacting to injury are unknown. Astrocytes react to injury by hypertrophy and up-regulation of the glial-fibrillary acidic protein (GFAP). Whereas mature astrocytes do not normally divide, a subpopulation of the reactive GFAP(+) cells does so, prompting the question of whether the proliferating GFAP(+) cells arise from endogenous glial progenitors or from mature astrocytes that start to proliferate in response to brain injury. Here we show by genetic fate mapping and cell type-specific viral targeting that quiescent astrocytes start to proliferate after stab wound injury and contribute to the reactive gliosis and proliferating GFAP(+) cells. These proliferating astrocytes remain within their lineage in vivo, while a more favorable environment in vitro revealed their multipotency and capacity for self-renewal. Conversely, progenitors present in the adult mouse cerebral cortex labeled by NG2 or the receptor for the platelet-derived growth factor (PDGFRalpha) did not form neurospheres after (or before) brain injury. Taken together, the first fate-mapping analysis of astrocytes in the adult mouse cerebral cortex shows that some astrocytes acquire stem cell properties after injury and hence may provide a promising cell type to initiate repair after brain injury.
                Bookmark

                Author and article information

                Journal
                Glia
                Glia
                10.1002/(ISSN)1098-1136
                GLIA
                Glia
                John Wiley and Sons Inc. (Hoboken )
                0894-1491
                1098-1136
                06 August 2015
                December 2015
                : 63
                : 12 ( doiID: 10.1002/glia.v63.12 )
                : 2340-2361
                Affiliations
                [ 1 ] Physiological Genomics, Biomedical CenterLudwig‐Maximilians‐University Munich Germany
                [ 2 ]Institute of Stem Cell Research, Helmholtz Center Munich, German Research Center for Environmental Health (GmbH) NeuherbergGermany
                [ 3 ]Institute of Experimental Genetics, Helmholtz Center Munich, German Research Center for Environmental Health (GmbH) NeuherbergGermany
                [ 4 ]Research Unit Protein Science, Helmholtz Center Munich, German Research Center for Environmental Health (GmbH) NeuherbergGermany
                [ 5 ] Department of PhysiologyFederal University of Sao Paulo Sao PauloBrazil
                [ 6 ]Institut Jacques Monod, CNRS‐University Paris Diderot ParisFrance
                [ 7 ]Chair of Experimental Genetics, Center of Life and Food Sciences Weihenstephan, Technische Universität München Freising‐WeihenstephanGermany
                [ 8 ] School of BiosciencesCardiff University CardiffUnited Kingdom
                [ 9 ]SYNERGY, Excellence Cluster of Systems Neurology, Ludwig‐Maximilians‐University Munich Germany
                Author notes
                [*] [* ]Address correspondence to Magdalena Götz; Institute for stem cell research, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. E‐mail: magdalena.goetz@ 123456helmholtz-muenchen.de
                Article
                GLIA22898
                10.1002/glia.22898
                5042059
                26250529
                da7dd2b9-86ac-41bd-a4af-d4bea96bc555
                © 2015 The Authors. Glia Published by Wiley Periodicals, Inc.

                This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 15 May 2015
                : 14 July 2015
                : 22 July 2015
                Page count
                Pages: 22
                Funding
                Funded by: DFG
                Award ID: SPP 1757 Functional heterogeneity of glia (MG)
                Award ID: SFB 871 neural Circuits (MG); HA 6014/2‐2 (SMH)
                Funded by: Synergy Excellence Cluster, the Helmholtz Foundation (ICEMED Alliance) (MG)
                Funded by: ERC
                Award ID: 340793 (MG)
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                glia22898
                December 2015
                Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:29.09.2016

                Neurosciences
                glia proliferation,neurosphere,genomewide analysis
                Neurosciences
                glia proliferation, neurosphere, genomewide analysis

                Comments

                Comment on this article